Suppression of autologous mixed leukocyte reaction in type 1 diabetes mellitus by in vivo-activated T lymphocytes

Clin Immunol Immunopathol. 1989 Sep;52(3):406-13. doi: 10.1016/0090-1229(89)90155-4.

Abstract

In vivo-activated interleukin 2 receptor-positive T lymphocytes (Tac cells) are demonstrable and the autologous mixed leukocyte reaction (AMLR) is impaired in several autoimmune diseases, including type 1 insulin-dependent diabetes mellitus (IDDM). We investigated AMLR in greater detail, together with possible relationships between AMLR and Tac lymphocytes in IDDM. Coculture experiments with HLA identical patient-healthy sibling pairs revealed that both responder and stimulator cells of diabetic patients function abnormally in AMLR. Suppressive Tac lymphocytes among responder T cells seemed to impair their proliferation. The removal of Tac cells by immunomagnetic beads led to a striking enhancement of proliferation, while the restoration of AMLR cultures with enriched Tac cells was accompanied by a diminished response. The reasons for the poor stimulatory capacity of patient cells are at present unknown but may be due to altered function and/or structure of HLA-DR molecules.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cells, Cultured
  • Child
  • Diabetes Mellitus, Type 1 / genetics
  • Diabetes Mellitus, Type 1 / immunology*
  • Family
  • HLA Antigens / analysis
  • HLA Antigens / genetics
  • Haplotypes
  • Humans
  • Lymphocyte Activation*
  • Lymphocyte Culture Test, Mixed
  • Receptors, Interleukin-2 / analysis
  • Reference Values
  • T-Lymphocytes / classification
  • T-Lymphocytes / immunology*

Substances

  • HLA Antigens
  • Receptors, Interleukin-2